JPS6254775B2 - - Google Patents

Info

Publication number
JPS6254775B2
JPS6254775B2 JP59198764A JP19876484A JPS6254775B2 JP S6254775 B2 JPS6254775 B2 JP S6254775B2 JP 59198764 A JP59198764 A JP 59198764A JP 19876484 A JP19876484 A JP 19876484A JP S6254775 B2 JPS6254775 B2 JP S6254775B2
Authority
JP
Japan
Prior art keywords
composition
composition according
warm
generating
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP59198764A
Other languages
English (en)
Japanese (ja)
Other versions
JPS60120817A (ja
Inventor
Reonaado Kantoreru Jon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIBI IMYUNOKEMU RISAACHI Inc
Original Assignee
RIBI IMYUNOKEMU RISAACHI Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIBI IMYUNOKEMU RISAACHI Inc filed Critical RIBI IMYUNOKEMU RISAACHI Inc
Publication of JPS60120817A publication Critical patent/JPS60120817A/ja
Publication of JPS6254775B2 publication Critical patent/JPS6254775B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59198764A 1983-09-23 1984-09-25 医療用組成物 Granted JPS60120817A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use
US535037 1983-09-23

Publications (2)

Publication Number Publication Date
JPS60120817A JPS60120817A (ja) 1985-06-28
JPS6254775B2 true JPS6254775B2 (cg-RX-API-DMAC7.html) 1987-11-17

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59198764A Granted JPS60120817A (ja) 1983-09-23 1984-09-25 医療用組成物

Country Status (23)

Country Link
US (1) US4663306A (cg-RX-API-DMAC7.html)
JP (1) JPS60120817A (cg-RX-API-DMAC7.html)
KR (1) KR870000843B1 (cg-RX-API-DMAC7.html)
AT (1) AT385659B (cg-RX-API-DMAC7.html)
AU (1) AU566234B2 (cg-RX-API-DMAC7.html)
BE (1) BE900650A (cg-RX-API-DMAC7.html)
CA (1) CA1244765A (cg-RX-API-DMAC7.html)
CH (1) CH664897A5 (cg-RX-API-DMAC7.html)
DE (1) DE3434766C2 (cg-RX-API-DMAC7.html)
DK (1) DK446684A (cg-RX-API-DMAC7.html)
ES (1) ES8608872A1 (cg-RX-API-DMAC7.html)
FI (1) FI843716L (cg-RX-API-DMAC7.html)
FR (1) FR2552326B1 (cg-RX-API-DMAC7.html)
GB (1) GB2149301B (cg-RX-API-DMAC7.html)
HU (1) HU192585B (cg-RX-API-DMAC7.html)
IL (1) IL73034A (cg-RX-API-DMAC7.html)
IN (1) IN157240B (cg-RX-API-DMAC7.html)
IT (1) IT1179444B (cg-RX-API-DMAC7.html)
NL (1) NL8402902A (cg-RX-API-DMAC7.html)
NO (1) NO843776L (cg-RX-API-DMAC7.html)
NZ (1) NZ209635A (cg-RX-API-DMAC7.html)
SE (1) SE8404707L (cg-RX-API-DMAC7.html)
ZA (1) ZA847405B (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
ATE210989T1 (de) * 1993-08-27 2002-01-15 Vetrepharm Inc Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
CA2299548C (en) 1997-08-05 2009-12-29 Bioniche Inc. Composition and method for regulating cell proliferation and cell death
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
KR100628007B1 (ko) 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
JP4772245B2 (ja) * 1999-12-13 2011-09-14 バイオニケ ライフ サイエンシーズ インコーポレイテッド 治療上有用な合成オリゴヌクレオチド
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
JP5106736B2 (ja) * 2000-07-11 2012-12-26 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト 臓器線維形成に対するパラポックスウイルスｏｖｉｓ株の使用
KR100820521B1 (ko) * 2002-03-05 2008-04-07 셀 메디신 가부시키가이샤 고체화 조직 면역아쥬반트
AU2003254792A1 (en) * 2002-08-02 2004-02-23 Sumitomo Pharmaceuticals Company, Limited Bacterial cell wall skeleton component preparaion
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
HK1214510A1 (zh) 2013-04-18 2016-07-29 Immune Design Corp. 用於癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
HUE071447T2 (hu) 2014-06-17 2025-08-28 Crown Laboratories Inc Genetikailag módosított baktériumok és eljárások baktériumok genetikai módosítására
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
EP3668957A4 (en) * 2017-08-17 2021-06-02 University of Delaware Furan based compositions and methods of making thereof
JP2023533202A (ja) 2020-06-23 2023-08-02 クラウン ラボラトリーズ，インコーポレイテッド プロバイオティクス皮膚製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (cg-RX-API-DMAC7.html) * 1972-06-20 1973-12-27
FR2269962B1 (cg-RX-API-DMAC7.html) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白ｗｅｎａｃ及びその製造法
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
SE8404707L (sv) 1985-03-24
SE8404707D0 (sv) 1984-09-20
IT1179444B (it) 1987-09-16
NZ209635A (en) 1989-01-27
BE900650A (fr) 1985-03-21
FI843716A7 (fi) 1985-03-24
ATA302384A (de) 1987-10-15
ZA847405B (en) 1985-05-29
FI843716A0 (fi) 1984-09-21
GB2149301B (en) 1988-06-22
ES536167A0 (es) 1986-07-16
HUT35521A (en) 1985-07-29
JPS60120817A (ja) 1985-06-28
KR870000843B1 (ko) 1987-04-25
NO843776L (no) 1985-03-25
IT8448894A0 (it) 1984-09-24
DE3434766A1 (de) 1986-04-30
IL73034A (en) 1988-11-15
GB2149301A (en) 1985-06-12
DE3434766C2 (de) 1987-05-14
CH664897A5 (de) 1988-04-15
FI843716L (fi) 1985-03-24
US4663306A (en) 1987-05-05
CA1244765A (en) 1988-11-15
AT385659B (de) 1988-05-10
IN157240B (cg-RX-API-DMAC7.html) 1986-02-15
FR2552326A1 (fr) 1985-03-29
AU566234B2 (en) 1987-10-15
KR850002404A (ko) 1985-05-13
AU3340084A (en) 1985-03-28
HU192585B (en) 1987-06-29
NL8402902A (nl) 1985-04-16
FR2552326B1 (fr) 1988-05-13
ES8608872A1 (es) 1986-07-16
DK446684A (da) 1985-03-24
DK446684D0 (da) 1984-09-19
GB8423993D0 (en) 1984-10-31

Similar Documents

Publication Publication Date Title
KR870000842B1 (ko) 정제 해독된 내독소 및 그의 제조방법
JPS6254775B2 (cg-RX-API-DMAC7.html)
US4436728A (en) Refined detoxified endotoxin product
US4435386A (en) Refined detoxified endotoxin product
US4877611A (en) Vaccine containing tumor antigens and adjuvants
US4505900A (en) Refined detoxified endotoxin product
US4505899A (en) Refined detoxified endotoxin product
US4504473A (en) Pyridine soluble extract of a microorganism
Butler et al. Combined immunostimulation in the prevention of tumor take in mice using endotoxins, their derivatives, and other immune adjuvants
JPH0556326B2 (cg-RX-API-DMAC7.html)
JPS6254774B2 (cg-RX-API-DMAC7.html)